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Introduction
The measurement of blood urea nitrogen (BUN) as
serum or plasma urea is one of the most frequently
ordered laboratory tests for evaluating renal functions.
Conventional analysis of reactions of urea with diacetyl
monoxime or urease with the Berthelot reaction [1] is
rapidly giving way to the totally enzymatic reactions that
are more convenient to perform and more easily adapted
to modern instrumentation. However, the automated
analysis ofthese reactions may yield falsely elevated BUN
levels for some patients.
The authors’ hospital recently acquired two new auto-
mated Hitachi analysers, Model 737 and 705 (Hitachi
737 Automatic Analyser and Hitachi 705 Automatic
Analyzer [trademarks of Hitachi Ltd, Tokyo, Japan and
marketed in the US by Boehringer Mannheim Diagnos-
tics, Indianapolis, Indiana 46250]; aca, Automated
Clinical Analyzer [trademark of Du Pont Instruments,
Wilmington, Delaware 19898, USA]; SMAC, Sequential
Multipole Analyzer with Computer [trademark ofTech-
nicon Instruments Corp., Tarrytown, New York 10591];
Ektachem 700 Analyzer [tradename of Eastman Kodak
Co., Rochester, New York 14650, USA); Astra [trade-
mark of Beckman Instruments Inc., Brea, California
92621, USA]). Attention was soon drawn to the BUN
analysis methods when it was discovered that one
patient’s serum had a BUN value of 950 mg/1 on the
Hitachi 737 and 370 mg/1 on the 705! In addition, both
instruments recorded creatinine values of 13 mg/1. The
marked difference in BUN values and the unusual
BUN-to-creatinine ratios on two instruments using
similar chemical methods prompted this study. As a
result of the study, such erroneous discrepancies have
been eliminated by developing a new reagent system and
a kinetic method 0fanalysis for the two Hitachi analysers.
Case report
A 73-year-old male who appeared healthy was admitted
for a minor surgical procedure involving the removal of a
small, metallic foreign body from his hand. A profile of
common chemistry tests were performed and all were
Table 1. General chemistry results.
Test Results Units Normal range
Gluc 940 mg/1 700.1100
BUN 950 mg/1 80-230
Creat 13 mg/1 8-15
Uric 65 mg/1 36-64
Na 142 nmol/1 135-145
K 4"7 mmol/1 3"4-5’0
CL 108 mmol/l 95-108
CO2 27 mmol/1 24-35
Ca 92 mg/1 90-106
Phos 34 mg/1 25-45
TP 77 g/1 60-80
Alb 37 g/1 30-50
Alkp 60 U/1 30-130
Ast 14 U/1 10-45
Alt 10 U/1 10-45
LD 160 U/1 25-200
Tbil 7 rag/1 0-12
Dbil 2 mg/1 0-2
Chol 2010 rag/1 1500-2500
Trig 1210 mg/1 100.1700
within normal limits with the exception of the BUN.
Table lists the patient’s results from the Hitachi 737.
Because of the unexplained and unusual BUN to
creatinine ratio, the patient’s operation was postponed
while these results were compared with analyses by
different chemical methods and the exact nature of the
problem was discovered.
Materials and methods
Boehringer Mannheim-Hitachi method
Two separate reagents, R1 NS R2 (cat. Nos. 804550 and
804568 respectively for the Hitachi 737 and cat. No.
620400 for both reagents on the Hitachi 705; Boehringer
Mannheim Diagnostics) were used. R1 contains NADH
as the reactive ingredient together with an unspecified
buffer and filler, which were defined by the manufacturer
as nonreactive ingredients [2]. R2 contains urease,
GLDH, and 2-oxogluarate in addition to an unspecified
buffer. On both instruments, serum or calibrator is mixed
with R1 and incubated for several minutes. At the end of
this incubation period an initial bichromatic absorbance
is measured as the difference between 376 nm and 660 nm
or between 376 nm and 415 nm on the Hitachi 737 and
705, respectively. R2 is then added, mixed, and incubated
for several additional minutes before a second bichro-
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matic absorbance measurement is taken. The BUN
concentration is proportional to the difference between
the first and second absorbance measurements after a
reagent blank is subtracted. The method is based on a
two-stage reaction in which urea is hydrolysed by urease
to form ammonia and CO2.
urease
urea+ H20 + 2H+2NH4
/ + CO.
In the presence ofGLDH and NADH, NH4+ reacts with
2-oxoglutarate to form L-glutamate and NAD+
GLDH
NH4+ + 2-oxoglutarate + NADH L-glutamate +
NAD+ + HO.
Table 2. Reagent composition.
Reagent 1
Componen Amount Units
Tris buffer 60 mmol/1
Adenosine-5’-diphosphate 1"5 mmol/1
NADH 0"27 mmol/1
Urease (Jack bean) 25,000 U/1
Glutamate dehydrogenase
(Bovine liver) 500 U/1
pH=8
Reagent 2
2-oxoglutarate 15 mmol/1
Table 3. Chemistry parameters for Hitachi 737.
Test name BUN
Assay code ENDP-1 i-20
Sample volume 4lal
R Vol. 300
R2 100 gl
Wavelength 340 nm
Wavelength 2 415 nm
Compensate limit 10"0
Calibration
Req. No. calib. Conc.
Saline 0
2) Calib. assigned value
Equation No. (1-5)
Factor (Fixed)
Unit factor 1"00
Abs. limit (rate) 0
Inc/Dec Dec
Denotes user or instrument specific settings.
Development ofa kinetic BUN method
Most commercial preparations for BUN reagents are
available in single reagent vials. However, this con-
venience is generally offset by a shorter viable life as
compared with two component reagent systems. Since
both Hitachi instruments are capable of adding two
reagents, a two-component reagent system was devised.
The method is a modification ofa single vial, kineticBUN
reagent produced by Reagent Applications. Reagent
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Table 4. Instrument setings for Hitachi 705.
Test code BUN
Assay code Rate- 19-24
Sample volume 4
R Vol. 300
Wavelength 415 nm
Wavelength 2 340 nm
Rgt. blk. abs. 0
Rgt. blk. conc. 0
Std. conc.
Factor 0
Std. abs. allowance 10%
Normal range L
Normal RangeH
Abs. limit (Rate) 10000
Control Id. No.
Denotes user or instrument specific settings.
Applications prepared the first reagent, R1, with all
components except 2-oxoglutarate, which they supplied
in a second vial as R2 (cat. No. 85146, Reagent
Applications, Inc., San Diego, California 92111, USA).
The composition of each reagent is listed in table 2. The
sample and all reagents, with the exception of2-oxogluta-
rate, are preincubated. 2-oxoglutarate is added as a start
reagent. Although the assay code for the Hitachi 737
specified an endpoint (ENDP), the manufacturer uses
this nomenclature for two-point kinetic reactions. This
code is used to take two separate absorbance readings
after the addition ofthe second reagent, R2. Tables 3 and
4 show the new instrument settings for the Hitachi 737
and 705, respectively. Both R1 and R2 are stored at 4C
and are stable for at least 10 days.
Results
Analyses by diffirent chemical methods
The BUN was measured on the DuPont aca, Technicon
SMAC, Kodak Ektachem 700, and Beckman Astra. The
results are summarized in table 5. The DuPont aca
method is a two-step kinetic enzymatic assay employing
urease and GLDH in which the sample is preincubated
with all reagents except 2-oxoglutarate, which is added as
a start reagent. On the SMAC, a diacetyl monoxime
method employing a dialysis step is used. The Ektachem
700 uses an enzymatic method with urease in a dry
chemistry slide. The Astra uses an enzymatic reaction
with urease and measures the rate of change in conduc-
tance. The BUN values from the aca, SMAC, Ektachem,
and Astra were similar and compatible with the patient’s
history, physical condition, and creatinine values.
Since both the Hitachi instruments and aca use similar
enzymatic reactions, the main differences between the
two systems are (1) the preincubation conditions; and (2)
the end point versus kinetic method for measuring
absorbance changes. Any type ofprecipitation that might
occur during the preincubation period and then dissolve
upon the addition of the second reagent would produce a
falsely elevated BUN by the Hitachi method but not by
the kinetic method or diacetyl monoxime method on the
SMAC.W. E. Neeley et al. Development of a kinetic BUN method
Table 5. Analysis ofpatient’s serum by different methods.
Instrument Method Result
Hitachi 737
Hitachi 705
DuPont aca
Technicon SMAC
Kodak Ektachem 700
Beckman astra
Hitachi 737
Hitachi 705
Enzymatic-end point*
Enzymatic-end point*
Enzymatic-kinetic
Diacetyl monoxime
Enzymatic-end point
Enzymatic-kinet!c
Proposed enzymatic-kinetic+ +
Proposed enyzmatic-kinetic++
950 rag/1
370 mg/1
230 rag/1
210 mg/1
200 mg/1
170 mg/1
230 mg/1
220 mg/l
* Boehringer-Mannheim Reagents.
+ + Reagent Applications, Inc. Reagents.
To test this possibility, the patient’s sample was mixed in
a test-tube with appropriate proportions of the BMD
reagent 1. A large amount of fine precipitation was
observed forming as the serum contacted the reagent.
When BMD reagent 2 was added and mixed the
precipitate completely disappeared. The exact cause of
the precipitation in BMD reagent is unknown, since the
composition of the R1 reagent is not given in the
manufacturer’s literature. It is known, however, that
patients with abnormally high levels of monoclonal
immunoglobulins are prone to precipitation [3]. A serum
protein electrophoresis confirmed our suspicion: a mono-
clonal peak was observed in the gamma globulin region.
Immunochemical analysis revealed in IgM level of21 g/1.
In addition, the patient was found to have an abundant
amount oflambda light chains in his urine. The patient’s
physician was notified and he is currently undergoing a
full medical evaluation to determine the exact aetiology of
his abnormal protein.
Linearity
Human serum pools containing very low and extremely
high urea concentrations were mixed in known propor-
tions and assayed in triplicate to determine the linearity
ofour method. It proved to be linear to at least 1000 mg/1
on both instruments.
Precision
For the Hitachi 737, the test for within-run precision was
performed by repeated analyses of sera from two different
patients. Patient 1" N 20, x 68 rag/l, SD 4, and CV
5"8%. Patient 2" N 20, x 448 mg/1, SD 12. and
CV 2"7%. Day-to-day precision was determined by
repeated daily analysis of two human-based commercial
control sera. Level 1" N 30, x 151 mg/1, SD 4.8, and
CV 3"2%. Level 2:N 30, x 510 mg/1, SD 10, and
CV 2"0%. For the Hitachi 705, the within-run
precision test was again performed by repeated analyses
of sera from two different patients. Patient 3"N 20, x
140 mg/1, SD 3"9, and CV 2"8%. Patient 4: N 20,
x 608 mg/1, SD 7"2, and CV 1"2%. Day-to-day
precision was determined by repeated daily analyses of
two human-based commercial control sera. Level 1’ N
112, x 150 mg/1, SD 10, and CV 3"7%. Level 2:
N 107, x 490 mg/1, SF 9, and CV 1"9%.
Correlation with a kinetic enzymatic method--randomly
selected serum samples were analysed in parallel on the
Hitachi 737 and on theCOBAS FARA (Roche Analytical
Instruments Inc., Nutley, New Jersey 07110, USA) with
enzymatic reagents from Reagent Applications, Inc. The
correlation statistics are N 80, y 0"983 x + 10, r
0"999, and Sy.x 14. At a later time, parallel analyses
were performed on the Hitachi 737 and 705 with
randomly selected serum samples using the proposed
enzymatic rate method on both instruments. ForN 31,
y 0"964 x 58, r 0"999, and Sy.x 39 where units are
in mg/1.
Discussion
Two additional patients tiave been found who produce
falsely elevated BUN values due to precipitation in R1
when analysed on the Hitachi 737 and 705 with BMD
reagents. It was interesting to note that each patient had
a different form of multiple myeloma; one patient had an
elevated IgG and the other an elevated IgA. The marked
discrepancies between BUN values on the Hitachi 737
and 705 were puzzling at first because both instruments
use similar reagents. It was discovered, however, that this
discrepancy was due to a difference in bichromatic
absorbance measurements made on the Hitachi 737 (376
nm and 660 nm) and on the Hitachi 705 (376 nm and 415
nm). Because a fine precipitate produces significantly less
absorbance at 660 nm than at 415 nm, the difference in
absorbance between 376 and 660 nm was much greater
than that observed between 376 and 415 nm.
In all three cases studied, normal BUN values were
obtained on both instruments by using the proposed
method. The method has been in use for over six months
without any problems. An additional advantage to the
new method is the improved day-to-day precision com-
pared to the original method using BMD reagents.
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